Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro-Reference-Cited by-同舟云学术

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

Published:2012-12 Issue:6 Volume:57 Page:1276-1282
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Pirazzi Carlo,Adiels Martin,Burza Maria Antonella,Mancina Rosellina Margherita,Levin Malin,Ståhlman Marcus,Taskinen Marja-Riitta,Orho-Melander Marju,Perman Jeanna,Pujia Arturo,Andersson Linda,Maglio Cristina,Montalcini Tiziana,Wiklund Olov,Borén Jan,Romeo Stefano

Publisher

Elsevier BV

Subject

Hepatology

Reference44 articles.

1. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study;Bedogni;Hepatology,2005

2. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

3. Nonalcoholic fatty liver disease in severely obese subjects;Gholam;Am J Gastroenterol,2007

4. Human fatty liver disease: old questions and new insights;Cohen;Science,2011

5. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease;Romeo;Nat Genet,2008

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic glucokinase regulatory protein and carbohydrate response element binding protein attenuation reduce de novo lipogenesis but do not mitigate intrahepatic triglyceride accumulation in Aldob deficiency;Molecular Metabolism;2024-09

2. A co-ordinated transcriptional programme in the maternal liver supplies long chain polyunsaturated fatty acids to the conceptus using phospholipids;Nature Communications;2024-08-08

3. Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study;Diabetes, Obesity and Metabolism;2024-07-18

4. Exploring the Role of Bempedoic Acid in Metabolic Dysfunction Associated Steatotic Liver Disease: Actual Evidence and Future Perspectives;International Journal of Molecular Sciences;2024-06-25

5. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping;World Journal of Gastrointestinal Pathophysiology;2024-05-24